Stay updated on Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page adds a new revision (v3.3.3) and removes the HHS Vulnerability Disclosure text along with the prior revision note (v3.3.2).SummaryDifference0.1%

- Check55 days agoChange DetectedFooter revision tag updated from 'Revision: v3.2.0' to 'Revision: v3.3.2'. This is a minor UI/version label change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding notice banner was removed from the page, and the study record history remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedThe history list now includes additional submission entries for the SWITCH PRO study (NCT03687827), documenting updates to study status and recruitment/locations. These entries reflect ongoing changes to the trial's status and site information.SummaryDifference0.1%

- Check105 days agoChange DetectedMajor update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.SummaryDifference10%

Stay in the know with updates to Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page.